Finance

Lists
SVA:TSE
Sernova Biotherapeutics Inc
0,12 CAD
0,00%
(0,00) 1D
9-окт., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Open
0,12 CAD
High
0,12 CAD
Low
0,12 CAD
Mkt. cap
41,53 млн
Avg. vol.
353,07 миң
Volume
16,36 миң
52-wk high
0,20 CAD
52-wk low
0,08 CAD
EPS
-0,03 CAD
Beta
32,05
Shares outstanding
377,64 млн
No. of employees
8
Open
0,12 CAD
High
0,12 CAD
Low
0,12 CAD
Mkt. cap
41,53 млн
Avg. vol.
353,07 миң
Volume
16,36 миң
52-wk high
0,20 CAD
52-wk low
0,08 CAD
EPS
-0,03 CAD
Beta
32,05
Shares outstanding
377,64 млн
No. of employees
8
News stories
From web sources and news partners
About Sernova Biotherapeutics Inc
CEOJonathan Rigby
Employees8
Founded2006
HeadquartersЛондон, Онтарио, Канада
Sector-
Last report
2026-ж., 10-сен.
Fiscal period
Q3 2026
-0,01 CAD / -0,00 CAD
-100,00%miss
Revenue / Est. (CAD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. окт.
2026-ж. янв.
2026-ж. апр.
2026-ж. июл.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
809,63 миң
434,15 миң
444,87 миң
432,62 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,59 млн
1,68 млн
1,85 млн
1,69 млн
Operating expense
2,40 млн
2,12 млн
2,30 млн
2,12 млн
Total operating expenses
2,40 млн
2,12 млн
2,30 млн
2,12 млн
Operating income
-2,40 млн
-2,12 млн
-2,30 млн
-2,12 млн
Other non operating income
-
-
-
-
EBT including unusual items
-2,25 млн
-2,41 млн
-3,23 млн
-2,57 млн
EBT excluding unusual items
-2,26 млн
-2,41 млн
-3,23 млн
-2,57 млн
Income tax expense
-54,97 миң
-72,00 миң
-
-45,00 миң
Effective tax rate
2,44%
2,99%
-
1,75%
Other operating expenses
-
-
-
-
Net income
-2,20 млн
-2,33 млн
-3,23 млн
-2,53 млн
Net profit margin
-
-
-
-
Earnings per share
-0,01
-0,01
-0,01
-0,01
Interest and investment income
260,60 миң
-
413,00
-
Interest expense
-
-477,12 миң
-920,95 миң
-260,18 миң
Net interest expenses
260,60 миң
-477,12 миң
-920,53 миң
-260,18 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,34 млн
-2,11 млн
-2,29 млн
-2,11 млн
Gain or loss from assets sale
-4,25 миң
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору